Annexin A1 as a key modulator of lung inflammation during coronavirus infections
Clinical Science · 27.11.2025 · 139 (22) · 1489-1505
DOI: 10.1042/cs20255801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, online erschienen am 17.11.2025. Verfasst von Filipe Resende und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil. Hauptthemen laut MEDLINE: Annexin A1, COVID-19, Lung, Pneumonia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Exacerbated inflammation is a major contributor to tissue damage and mortality in infectious diseases, including SARS-CoV-2. The resolution phase of inflammation is critical for restoring tissue homeostasis following an injury. Annexin A1 (AnxA1) is a ubiquitous protein that plays a fundamental role in the resolution of inflammation, including in preclinical models of infectious disease. Here, we investigated the role of AnxA1 in coronavirus infection and its potential as a host-targeted therapeutic strategy against SARS-CoV-2. Wildtype (WT) and AnxA1 knockout (AnxA1KO) mice were intranasally infected with the murine betacoronavirus MHV-3 to study the endogenous role of AnxA1. Immunohistochemistry and Western blot analyses in the lungs of MHV-3-infected mice revealed increased AnxA1 expression and its cleavage, which was associated with neutrophilic infiltration (Ly6G+ cells) mainly in peribronchiolar and perivascular regions. AnxA1-deficient mice exhibited higher neutrophilic infiltration and lung damage, alongside increased CXCL1 production in the lungs, when compared with WT-infected mice. In a murine model of SARS-CoV-2 infection in K18-hACE2 mice, we found increased AnxA1 cleavage associated with lung inflammation. Treatment of SARS-CoV-2-infected K18-hACE2 mice with the AnxA1-mimetic peptide, Ac2-26, reduced lung damage and lethality, without altering the host ability to deal with viral replication. Notably, Ac2-26-treated mice exhibited similar levels of protection to that afforded by the nucleotide analog Remdesivir, following SARS-CoV-2 infection. Our findings highlight the protective role of the endogenous AnxA1 in mitigating coronavirus-induced lung inflammation and underscore the therapeutic potential of AnxA1 mimetic Ac2-26 as a host-targeted therapy against SARS-CoV-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Morphology, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil.
- Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil.
- Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil.
- Department of Phisiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil.
- Signaling in Inflammation Laboratory, Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
- Department of Obstetrics, Gynecology and Reproduction, Université Laval, Quebec City, Québec, Canada.
ORCID-Profile: Vivian V Costa
Zitieren
APA
Resende, F., Queiroz-Junior, C., Ascenção, F. R., Chaves, I. M., de Souza Barbosa Lacerda, L., Rocha, F., Teixeira, D., Galvão, I., Costa, V., Fonseca, T., Gualberto, A., de Castro Santos, A. L., Martins, J., de Sousa Lima, E. B., Alves Monteiro, A. H., Zaidan, I., Grossi, L. C., Carvalho Costa, P. A., Amorim Beltrami, V., …, & Costa, V. V. (2025). Annexin A1 as a key modulator of lung inflammation during coronavirus infections. Clinical Science, 139(22), 1489-1505. https://doi.org/10.1042/cs20255801
Vancouver
Resende F, Queiroz-Junior C, Ascenção FR, Chaves IM, de Souza Barbosa Lacerda L, Rocha F, et al. Annexin A1 as a key modulator of lung inflammation during coronavirus infections. Clinical Science. 2025;139(22):1489-1505. doi:10.1042/cs20255801
BibTeX
@article{Resende2025,
author = {Resende, Filipe and Queiroz-Junior, Celso and Ascenção, Fernando Roque and Chaves, Ian de Meira and de Souza Barbosa Lacerda, Larisse and Rocha, Felipe and Teixeira, Danielle and Galvão, Izabela and Costa, Victor and Fonseca, Talita and Gualberto, Arthur and de Castro Santos, Ana Luiza and Martins, Jenniffer and de Sousa Lima, Erick Bryan and Alves Monteiro, Adelson Héric and Zaidan, Isabella and Grossi, Laís C and Carvalho Costa, Pedro Augusto and Amorim Beltrami, Vinicius and Sousa, Lirlândia P and Pires Goulart Guimarães, Pedro and Campolina-Silva, Gabriel and Teixeira, Mauro M and Pinho, Vanessa and Costa, Vivian V},
title = {Annexin A1 as a key modulator of lung inflammation during coronavirus infections},
journal = {Clinical Science},
year = {2025},
volume = {139},
number = {22},
pages = {1489--1505},
doi = {10.1042/cs20255801}
}
EUVIMED